Last 12 months
Inside the activity.
1 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 27, 2020 Filed Jul 31, 2020 20:50 UTC |
Harsanyi ZsoltDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 892 | Not disclosed Strike: $30.10 | Not disclosed |
DisclosureSEC source: 0001019056-20-000452 · harsanyi.xml · derivative · entry 2 Harsanyi Zsolt · CIK 0001380184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 892 shares Expires 2027-06-01 F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4. F4 · derivative.exercise_date: These options vested in three approximately equal annual installments beginning on June 1, 2018. F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. Read SEC document |
| July 27, 2020 Filed Jul 31, 2020 20:50 UTC |
Harsanyi ZsoltDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 1,339 | Not disclosed Strike: $41.16 | Not disclosed |
DisclosureSEC source: 0001019056-20-000452 · harsanyi.xml · derivative · entry 1 Harsanyi Zsolt · CIK 0001380184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,339 shares Expires 2026-08-03 F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4. F2 · derivative.exercise_date: These options vested in three approximately equal annual installments beginning on August 3, 2017. F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. Read SEC document |
| July 27, 2020 Filed Jul 30, 2020 01:40 UTC |
White Marvin LDirector · CEO and President
|
GrantStock Option (right to buy) · Derivative | 4,813 | Not disclosed Strike: $8.56 | Not disclosed |
DisclosureSEC source: 0001019056-20-000441 · white.xml · derivative · entry 8 White Marvin L · CIK 0001493324 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,813 Underlying: Common Stock · 4,813 shares Expires 2030-07-26 F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4. F10 · derivative.exercise_date: These options will vest in three approximately equal annual installments beginning on the one year anniversary of the date of grant. Read SEC document |
| July 27, 2020 Filed Jul 30, 2020 01:40 UTC |
White Marvin LDirector · CEO and President
|
GrantStock Option (right to buy) · Derivative | 16,625 | Not disclosed Strike: $8.56 | Not disclosed |
DisclosureSEC source: 0001019056-20-000441 · white.xml · derivative · entry 7 White Marvin L · CIK 0001493324 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,625 Underlying: Common Stock · 16,625 shares Expires 2030-07-26 F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4. F9 · derivative.exercise_date: These options vest in full on the one year anniversary of the date of grant. Read SEC document |
| July 27, 2020 Filed Jul 30, 2020 01:40 UTC |
White Marvin LDirector · CEO and President
|
Disposition to issuerStock Option (right to buy) · Derivative | 10,828 | Not disclosed Strike: $21.28 | Not disclosed |
DisclosureSEC source: 0001019056-20-000441 · white.xml · derivative · entry 6 White Marvin L · CIK 0001493324 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,828 shares Expires 2029-02-28 F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4. F8 · derivative.exercise_date: This stock option award provides for vesting in three approximately equal annual installments beginning on February 28, 2020. Prior to July 27, 2020, all but 7,219 shares of the issuer's common stock underlying this stock option had vested. F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. Read SEC document |
| July 27, 2020 Filed Jul 30, 2020 01:40 UTC |
White Marvin LDirector · CEO and President
|
Disposition to issuerStock Option (right to buy) · Derivative | 10,828 | Not disclosed Strike: $43.82 | Not disclosed |
DisclosureSEC source: 0001019056-20-000441 · white.xml · derivative · entry 5 White Marvin L · CIK 0001493324 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,828 shares Expires 2028-03-09 F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4. F7 · derivative.exercise_date: This stock option award provides for vesting in three approximately equal annual installments beginning on March 9, 2019. Prior to July 27, 2020, all but 3,609 shares of the issuer's common stock underlying this stock option had vested. F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. Read SEC document |
| July 27, 2020 Filed Jul 30, 2020 01:40 UTC |
White Marvin LDirector · CEO and President
|
Disposition to issuerStock Option (right to buy) · Derivative | 5,414 | Not disclosed Strike: $30.10 | Not disclosed |
DisclosureSEC source: 0001019056-20-000441 · white.xml · derivative · entry 4 White Marvin L · CIK 0001493324 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,414 shares Expires 2027-06-01 F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4. F6 · derivative.exercise_date: This stock option award vested over three years, and the final one-third vested on June 1, 2020. F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. Read SEC document |
| July 27, 2020 Filed Jul 30, 2020 01:40 UTC |
White Marvin LDirector · CEO and President
|
Disposition to issuerStock Option (right to buy) · Derivative | 5,414 | Not disclosed Strike: $27.44 | Not disclosed |
DisclosureSEC source: 0001019056-20-000441 · white.xml · derivative · entry 3 White Marvin L · CIK 0001493324 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,414 shares Expires 2027-02-24 F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4. F5 · derivative.exercise_date: This stock option award vested over three years, and the final one-third vested on February 24, 2020. F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. Read SEC document |
| July 27, 2020 Filed Jul 30, 2020 01:40 UTC |
White Marvin LDirector · CEO and President
|
Disposition to issuerStock Option (right to buy) · Derivative | 14,319 | Not disclosed Strike: $41.16 | Not disclosed |
DisclosureSEC source: 0001019056-20-000441 · white.xml · derivative · entry 2 White Marvin L · CIK 0001493324 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,319 shares Expires 2026-08-03 F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4. F4 · derivative.exercise_date: This stock option award vested over three years, and the final one-third vested on August 3, 2019. F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. Read SEC document |
| July 27, 2020 Filed Jul 30, 2020 01:40 UTC |
White Marvin LDirector · CEO and President
|
Disposition to issuerStock Option (right to buy) · Derivative | 2,545 | Not disclosed Strike: $25.20 | Not disclosed |
DisclosureSEC source: 0001019056-20-000441 · white.xml · derivative · entry 1 White Marvin L · CIK 0001493324 · Director · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,545 shares Expires 2021-05-22 F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4. F2 · derivative.exercise_date: The stock option award vested on May 22, 2017. This award was originally part of a grant from Emergent BioSolutions Inc. ("Emergent") dated May 22, 2014 of which two-thirds were vested at the time of conversion to issuer's equity pool. F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. Read SEC document |
| July 27, 2020 Filed Jul 30, 2020 01:39 UTC |
Niederhuber JohnDirector
|
GrantStock Option (right to buy) · Derivative | 170 | Not disclosed Strike: $8.56 | Not disclosed |
DisclosureSEC source: 0001019056-20-000440 · niederhuber.xml · derivative · entry 5 Niederhuber John · CIK 0001501240 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170 Underlying: Common Stock · 170 shares Expires 2030-07-26 F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4. F7 · derivative.exercise_date: These options will vest in three approximately equal annual installments beginning on the one year anniversary of the date of grant. Read SEC document |
| July 27, 2020 Filed Jul 30, 2020 01:39 UTC |
Niederhuber JohnDirector
|
GrantStock Option (right to buy) · Derivative | 1,322 | Not disclosed Strike: $8.56 | Not disclosed |
DisclosureSEC source: 0001019056-20-000440 · niederhuber.xml · derivative · entry 4 Niederhuber John · CIK 0001501240 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,322 Underlying: Common Stock · 1,322 shares Expires 2030-07-26 F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4. F6 · derivative.exercise_date: These options vest in full on the one year anniversary of the date of grant. Read SEC document |
| July 27, 2020 Filed Jul 30, 2020 01:39 UTC |
Niederhuber JohnDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 1,785 | Not disclosed Strike: $76.86 | Not disclosed |
DisclosureSEC source: 0001019056-20-000440 · niederhuber.xml · derivative · entry 3 Niederhuber John · CIK 0001501240 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,785 shares Expires 2028-06-01 F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4. F5 · derivative.exercise_date: These options provide for vesting in three approximately equal annual installments beginning on May 31, 2019. Prior to July 27, 2020, all but 595 shares of the issuer's common stock underlying this stock option had vested. F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. Read SEC document |
| July 27, 2020 Filed Jul 30, 2020 01:39 UTC |
Niederhuber JohnDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 892 | Not disclosed Strike: $30.10 | Not disclosed |
DisclosureSEC source: 0001019056-20-000440 · niederhuber.xml · derivative · entry 2 Niederhuber John · CIK 0001501240 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 892 shares Expires 2027-06-01 F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4. F4 · derivative.exercise_date: These options vested in three approximately equal annual installments beginning on June 1, 2018. F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. Read SEC document |
| July 27, 2020 Filed Jul 30, 2020 01:39 UTC |
Niederhuber JohnDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 1,339 | Not disclosed Strike: $41.16 | Not disclosed |
DisclosureSEC source: 0001019056-20-000440 · niederhuber.xml · derivative · entry 1 Niederhuber John · CIK 0001501240 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,339 shares Expires 2026-08-03 F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4. F2 · derivative.exercise_date: These options vested in three approximately equal annual installments beginning on August 3, 2017. F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. Read SEC document |
| July 27, 2020 Filed Jul 30, 2020 01:23 UTC |
Grant Grady IIIDirector
|
GrantStock Option (right to buy) · Derivative | 170 | Not disclosed Strike: $8.56 | Not disclosed |
DisclosureSEC source: 0001019056-20-000438 · grant.xml · derivative · entry 5 Grant Grady III · CIK 0001679966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170 Underlying: Common Stock · 170 shares Expires 2030-07-26 F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4. F7 · derivative.exercise_date: These options will vest in three approximately equal annual installments beginning on the one year anniversary of the date of grant. Read SEC document |
| July 27, 2020 Filed Jul 30, 2020 01:23 UTC |
Grant Grady IIIDirector
|
GrantStock Option (right to buy) · Derivative | 1,322 | Not disclosed Strike: $8.56 | Not disclosed |
DisclosureSEC source: 0001019056-20-000438 · grant.xml · derivative · entry 4 Grant Grady III · CIK 0001679966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,322 Underlying: Common Stock · 1,322 shares Expires 2030-07-26 F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4. F6 · derivative.exercise_date: These options vest in full on the one year anniversary of the date of grant. Read SEC document |
| July 27, 2020 Filed Jul 30, 2020 01:23 UTC |
Grant Grady IIIDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 1,785 | Not disclosed Strike: $76.86 | Not disclosed |
DisclosureSEC source: 0001019056-20-000438 · grant.xml · derivative · entry 3 Grant Grady III · CIK 0001679966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,785 shares Expires 2028-06-01 F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4. F5 · derivative.exercise_date: These options provide for vesting in three approximately equal annual installments beginning on May 31, 2019. Prior to July 27, 2020, all but 595 shares of the issuer's common stock underlying this stock option had vested. F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. Read SEC document |
| July 27, 2020 Filed Jul 30, 2020 01:23 UTC |
Grant Grady IIIDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 892 | Not disclosed Strike: $30.10 | Not disclosed |
DisclosureSEC source: 0001019056-20-000438 · grant.xml · derivative · entry 2 Grant Grady III · CIK 0001679966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 892 shares Expires 2027-06-01 F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4. F4 · derivative.exercise_date: These options vested in three approximately equal annual installments beginning on June 1, 2018. F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. Read SEC document |
| July 27, 2020 Filed Jul 30, 2020 01:23 UTC |
Grant Grady IIIDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 1,339 | Not disclosed Strike: $41.16 | Not disclosed |
DisclosureSEC source: 0001019056-20-000438 · grant.xml · derivative · entry 1 Grant Grady III · CIK 0001679966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,339 shares Expires 2026-08-03 F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4. F2 · derivative.exercise_date: These options vested in three approximately equal annual installments beginning on August 3, 2017. F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. Read SEC document |
| July 27, 2020 Filed Jul 30, 2020 01:18 UTC |
Kunz Barbara LopezDirector
|
GrantStock Option (right to buy) · Derivative | 170 | Not disclosed Strike: $8.56 | Not disclosed |
DisclosureSEC source: 0001019056-20-000437 · kunz.xml · derivative · entry 5 Kunz Barbara Lopez · CIK 0001679970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170 Underlying: Common Stock · 170 shares Expires 2030-07-26 F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4. F7 · derivative.exercise_date: These options will vest in three approximately equal annual installments beginning on the one year anniversary of the date of grant. Read SEC document |
| July 27, 2020 Filed Jul 30, 2020 01:18 UTC |
Kunz Barbara LopezDirector
|
GrantStock Option (right to buy) · Derivative | 1,322 | Not disclosed Strike: $8.56 | Not disclosed |
DisclosureSEC source: 0001019056-20-000437 · kunz.xml · derivative · entry 4 Kunz Barbara Lopez · CIK 0001679970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,322 Underlying: Common Stock · 1,322 shares Expires 2030-07-26 F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4. F6 · derivative.exercise_date: These options vest in full on the one year anniversary of the date of grant. Read SEC document |
| July 27, 2020 Filed Jul 30, 2020 01:18 UTC |
Kunz Barbara LopezDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 1,785 | Not disclosed Strike: $76.86 | Not disclosed |
DisclosureSEC source: 0001019056-20-000437 · kunz.xml · derivative · entry 3 Kunz Barbara Lopez · CIK 0001679970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,785 shares Expires 2028-06-01 F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4. F5 · derivative.exercise_date: These options provide for vesting in three approximately equal annual installments beginning on May 31, 2019. Prior to July 27, 2020, all but 595 shares of the issuer's common stock underlying this stock option had vested. F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. Read SEC document |
| July 27, 2020 Filed Jul 30, 2020 01:18 UTC |
Kunz Barbara LopezDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 892 | Not disclosed Strike: $30.10 | Not disclosed |
DisclosureSEC source: 0001019056-20-000437 · kunz.xml · derivative · entry 2 Kunz Barbara Lopez · CIK 0001679970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 892 shares Expires 2027-06-01 F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4. F4 · derivative.exercise_date: These options vested in three approximately equal annual installments beginning on June 1, 2018. F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. Read SEC document |
| July 27, 2020 Filed Jul 30, 2020 01:18 UTC |
Kunz Barbara LopezDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 1,339 | Not disclosed Strike: $41.16 | Not disclosed |
DisclosureSEC source: 0001019056-20-000437 · kunz.xml · derivative · entry 1 Kunz Barbara Lopez · CIK 0001679970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,339 shares Expires 2026-08-03 F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4. F2 · derivative.exercise_date: These options vested in three approximately equal annual installments beginning on August 3, 2017. F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. Read SEC document |
| July 27, 2020 Filed Jul 30, 2020 01:18 UTC |
El-Hibri FuadDirector
|
GrantStock Option (right to buy) · Derivative | 170 | Not disclosed Strike: $8.56 | Not disclosed |
DisclosureSEC source: 0001019056-20-000436 · elhibri.xml · derivative · entry 5 El-Hibri Fuad · CIK 0001380185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170 Underlying: Common Stock · 170 shares Expires 2030-07-26 F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4. F7 · derivative.exercise_date: These options will vest in three approximately equal annual installments beginning on the one year anniversary of the date of grant. Read SEC document |
| July 27, 2020 Filed Jul 30, 2020 01:18 UTC |
El-Hibri FuadDirector
|
GrantStock Option (right to buy) · Derivative | 1,322 | Not disclosed Strike: $8.56 | Not disclosed |
DisclosureSEC source: 0001019056-20-000436 · elhibri.xml · derivative · entry 4 El-Hibri Fuad · CIK 0001380185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,322 Underlying: Common Stock · 1,322 shares Expires 2030-07-26 F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4. F6 · derivative.exercise_date: These options vest in full on the one year anniversary of the date of grant. Read SEC document |
| July 27, 2020 Filed Jul 30, 2020 01:18 UTC |
El-Hibri FuadDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 1,785 | Not disclosed Strike: $76.86 | Not disclosed |
DisclosureSEC source: 0001019056-20-000436 · elhibri.xml · derivative · entry 3 El-Hibri Fuad · CIK 0001380185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,785 shares Expires 2028-06-01 F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4. F5 · derivative.exercise_date: These options provide for vesting in three approximately equal annual installments beginning on May 31, 2019. Prior to July 27, 2020, all but 595 shares of the issuer's common stock underlying this stock option had vested. F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. Read SEC document |
| July 27, 2020 Filed Jul 30, 2020 01:18 UTC |
El-Hibri FuadDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 892 | Not disclosed Strike: $30.10 | Not disclosed |
DisclosureSEC source: 0001019056-20-000436 · elhibri.xml · derivative · entry 2 El-Hibri Fuad · CIK 0001380185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 892 shares Expires 2027-06-01 F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4. F4 · derivative.exercise_date: These options vested in three approximately equal annual installments beginning on June 1, 2018. F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. Read SEC document |
| July 27, 2020 Filed Jul 30, 2020 01:18 UTC |
El-Hibri FuadDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 1,339 | Not disclosed Strike: $41.16 | Not disclosed |
DisclosureSEC source: 0001019056-20-000436 · elhibri.xml · derivative · entry 1 El-Hibri Fuad · CIK 0001380185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,339 shares Expires 2026-08-03 F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4. F2 · derivative.exercise_date: These options vested in three approximately equal annual installments beginning on August 3, 2017. F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. Read SEC document |
| July 27, 2020 Filed Jul 30, 2020 01:11 UTC |
Abdun-Nabi DanielDirector
|
GrantStock Option (right to buy) · Derivative | 170 | Not disclosed Strike: $8.56 | Not disclosed |
DisclosureSEC source: 0001019056-20-000433 · abdunnabi.xml · derivative · entry 5 Abdun-Nabi Daniel · CIK 0001380187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 170 Underlying: Common Stock · 170 shares Expires 2030-07-26 F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4. F7 · derivative.exercise_date: These options will vest in three approximately equal annual installments beginning on the one year anniversary of the date of grant. Read SEC document |
| July 27, 2020 Filed Jul 30, 2020 01:11 UTC |
Abdun-Nabi DanielDirector
|
GrantStock Option (right to buy) · Derivative | 1,322 | Not disclosed Strike: $8.56 | Not disclosed |
DisclosureSEC source: 0001019056-20-000433 · abdunnabi.xml · derivative · entry 4 Abdun-Nabi Daniel · CIK 0001380187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,322 Underlying: Common Stock · 1,322 shares Expires 2030-07-26 F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4. F6 · derivative.exercise_date: These options vest in full on the one year anniversary of the date of grant. Read SEC document |
| July 27, 2020 Filed Jul 30, 2020 01:11 UTC |
Abdun-Nabi DanielDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 1,785 | Not disclosed Strike: $76.86 | Not disclosed |
DisclosureSEC source: 0001019056-20-000433 · abdunnabi.xml · derivative · entry 3 Abdun-Nabi Daniel · CIK 0001380187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,785 shares Expires 2028-06-01 F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4. F5 · derivative.exercise_date: These options provide for vesting in three approximately equal annual installments beginning on May 31, 2019. Prior to July 27, 2020, all but 595 shares of the issuer's common stock underlying this stock option had vested. F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. Read SEC document |
| July 27, 2020 Filed Jul 30, 2020 01:11 UTC |
Abdun-Nabi DanielDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 892 | Not disclosed Strike: $30.10 | Not disclosed |
DisclosureSEC source: 0001019056-20-000433 · abdunnabi.xml · derivative · entry 2 Abdun-Nabi Daniel · CIK 0001380187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 892 shares Expires 2027-06-01 F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4. F4 · derivative.exercise_date: These options vested in three approximately equal annual installments beginning on June 1, 2018. F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. Read SEC document |
| July 27, 2020 Filed Jul 30, 2020 01:11 UTC |
Abdun-Nabi DanielDirector
|
Disposition to issuerStock Option (right to buy) · Derivative | 1,339 | Not disclosed Strike: $41.16 | Not disclosed |
DisclosureSEC source: 0001019056-20-000433 · abdunnabi.xml · derivative · entry 1 Abdun-Nabi Daniel · CIK 0001380187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,339 shares Expires 2026-08-03 F1 · derivative.exercise_price: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F1 · shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. F3 · price: In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4. F2 · derivative.exercise_date: These options vested in three approximately equal annual installments beginning on August 3, 2017. F1 · derivative.underlying_shares: Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020. Read SEC document |
| July 02, 2020 Filed Feb 18, 2021 02:03 UTC |
Niederhuber JohnDirector
|
GrantStock Option (right to buy) · Derivative | 3,571 | $0.00 Strike: $9.18 | $0.00 |
DisclosureSEC source: 0001019056-21-000146 · niederhuber.xml · derivative · entry 1 Niederhuber John · CIK 0001501240 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,571 Underlying: Common Stock · 3,571 shares Expires 2030-07-02 F1 · derivative.exercise_date: The option vests in three approximately equal annual installments beginning on July 2, 2021. Read SEC document |
| July 02, 2020 Filed Feb 18, 2021 02:02 UTC |
Kunz Barbara LopezDirector
|
GrantStock Option (right to buy) · Derivative | 3,571 | $0.00 Strike: $9.18 | $0.00 |
DisclosureSEC source: 0001019056-21-000144 · kunz.xml · derivative · entry 1 Kunz Barbara Lopez · CIK 0001679970 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,571 Underlying: Common Stock · 3,571 shares Expires 2030-07-02 F1 · derivative.exercise_date: The option vests in three approximately equal annual installments beginning on July 2, 2021. Read SEC document |
| July 02, 2020 Filed Feb 18, 2021 02:01 UTC |
Harsanyi ZsoltDirector
|
GrantStock Option (right to buy) · Derivative | 3,571 | $0.00 Strike: $9.18 | $0.00 |
DisclosureSEC source: 0001019056-21-000143 · harsanyi.xml · derivative · entry 1 Harsanyi Zsolt · CIK 0001380184 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,571 Underlying: Common Stock · 3,571 shares Expires 2030-07-02 F1 · derivative.exercise_date: The option vests in three approximately equal annual installments beginning on July 2, 2021. Read SEC document |
| July 02, 2020 Filed Feb 18, 2021 02:00 UTC |
Grant Grady IIIDirector
|
GrantStock Option (right to buy) · Derivative | 3,571 | $0.00 Strike: $9.18 | $0.00 |
DisclosureSEC source: 0001019056-21-000141 · grant.xml · derivative · entry 1 Grant Grady III · CIK 0001679966 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,571 Underlying: Common Stock · 3,571 shares Expires 2030-07-02 F1 · derivative.exercise_date: The option vests in three approximately equal annual installments beginning on July 2, 2021. Read SEC document |
| July 02, 2020 Filed Feb 18, 2021 02:00 UTC |
El-Hibri FuadDirector
|
GrantStock Option (right to buy) · Derivative | 3,571 | $0.00 Strike: $9.18 | $0.00 |
DisclosureSEC source: 0001019056-21-000140 · elhibri.xml · derivative · entry 1 El-Hibri Fuad · CIK 0001380185 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,571 Underlying: Common Stock · 3,571 shares Expires 2030-07-02 F1 · derivative.exercise_date: The option vests in three approximately equal annual installments beginning on July 2, 2021. Read SEC document |
| July 02, 2020 Filed Feb 18, 2021 01:59 UTC |
Abdun-Nabi DanielDirector
|
GrantStock Option (right to buy) · Derivative | 3,571 | $0.00 Strike: $9.18 | $0.00 |
DisclosureSEC source: 0001019056-21-000139 · abdunnabi.xml · derivative · entry 1 Abdun-Nabi Daniel · CIK 0001380187 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,571 Underlying: Common Stock · 3,571 shares Expires 2030-07-02 F1 · derivative.exercise_date: The option vests in three approximately equal annual installments beginning on July 2, 2021. Read SEC document |
| February 18, 2020 Filed Mar 19, 2020 22:33 UTC |
Gross Jane ASVP & Chief Scientific Officer
|
GrantStock Option (right to buy) · Derivative | 134,800 | $0.00 Strike: $0.50 | $0.00 |
DisclosureSEC source: 0001019056-20-000240 · gross.xml · derivative · entry 1 Gross Jane A · CIK 0001684258 · SVP & Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,800 Underlying: Common Stock · 134,800 shares Expires 2030-02-17 F1 · derivative.exercise_date: The option vests in three approximately equal annual installments beginning on February 17, 2021. Read SEC document |
| February 18, 2020 Filed Mar 19, 2020 18:34 UTC |
Maddux Randy JoeSVP Operations, CMO
|
GrantStock Option (right to buy) · Derivative | 134,800 | $0.00 Strike: $0.50 | $0.00 |
DisclosureSEC source: 0001019056-20-000242 · maddux_4.xml · derivative · entry 1 Maddux Randy Joe · CIK 0001683826 · SVP Operations, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,800 Underlying: Common Stock · 134,800 shares Expires 2030-02-17 F1 · derivative.exercise_date: The option vests in three approximately equal annual installments beginning on February 17, 2021. Read SEC document |
| February 18, 2020 Filed Mar 19, 2020 22:35 UTC |
White Marvin LDirector · President and CEO
|
GrantStock Option (right to buy) · Derivative | 303,200 | $0.00 Strike: $0.50 | $0.00 |
DisclosureSEC source: 0001019056-20-000244 · white.xml · derivative · entry 1 White Marvin L · CIK 0001493324 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 303,200 Underlying: Common Stock · 303,200 shares Expires 2030-02-17 F1 · derivative.exercise_date: The option vests in three approximately equal annual installments beginning on February 17, 2021. Read SEC document |
| February 18, 2020 Filed Mar 19, 2020 22:34 UTC |
Mitchell ShawnteSVP, GC and Corporate Affairs
|
GrantStock Option (right to buy) · Derivative | 134,800 | $0.00 Strike: $0.50 | $0.00 |
DisclosureSEC source: 0001019056-20-000243 · mitchell.xml · derivative · entry 1 Mitchell Shawnte · CIK 0001749432 · SVP, GC and Corporate Affairs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,800 Underlying: Common Stock · 134,800 shares Expires 2030-02-17 F1 · derivative.exercise_date: The option vests in three approximately equal annual installments beginning on February 17, 2021. Read SEC document |
| February 18, 2020 Filed Mar 19, 2020 22:34 UTC |
Lamothe Jeffrey G.SVP and CFO
|
GrantStock Option (right to buy) · Derivative | 134,800 | $0.00 Strike: $0.50 | $0.00 |
DisclosureSEC source: 0001019056-20-000241 · lamothe.xml · derivative · entry 1 Lamothe Jeffrey G. · CIK 0001679967 · SVP and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,800 Underlying: Common Stock · 134,800 shares Expires 2030-02-17 F1 · derivative.exercise_date: The option vests in three approximately equal annual installments beginning on February 17, 2021. Read SEC document |
| February 18, 2020 Filed Mar 19, 2020 22:33 UTC |
Adelman MichaelSVP, Commercial Operations
|
GrantStock Option (right to buy) · Derivative | 134,800 | $0.00 Strike: $0.50 | $0.00 |
DisclosureSEC source: 0001019056-20-000239 · adelman.xml · derivative · entry 1 Adelman Michael · CIK 0001749435 · SVP, Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,800 Underlying: Common Stock · 134,800 shares Expires 2030-02-17 F1 · derivative.exercise_date: The option vests in three approximately equal annual installments beginning on February 17, 2021. Read SEC document |
| November 01, 2019 Filed Nov 6, 2019 01:50 UTC |
Adelman MichaelSVP, Commercial Operations
|
GrantStock Option (right to buy) · Derivative | 114,247 | $0.00 Strike: $0.58 | $0.00 |
DisclosureSEC source: 0001019056-19-000610 · adelman.xml · derivative · entry 1 Adelman Michael · CIK 0001749435 · SVP, Commercial Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,247 Underlying: Common Stock · 114,247 shares Expires 2029-10-31 F1 · derivative.exercise_date: The options vest on November 1, 2020, the one-year anniversary of the grant date. Read SEC document |
| November 01, 2019 Filed Nov 6, 2019 01:52 UTC |
Gross Jane ASee Remarks
|
GrantStock Option (right to buy) · Derivative | 122,982 | $0.00 Strike: $0.58 | $0.00 |
DisclosureSEC source: 0001019056-19-000612 · gross.xml · derivative · entry 1 Gross Jane A · CIK 0001684258 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,982 Underlying: Common Stock · 122,982 shares Expires 2029-10-31 F1 · derivative.exercise_date: The options vest on November 1, 2020, the one-year anniversary of the grant date. Read SEC document |
| November 01, 2019 Filed Nov 5, 2019 20:54 UTC |
Maddux Randy JoeSVP Operations, CMO
|
GrantStock Option (right to buy) · Derivative | 122,359 | $0.00 Strike: $0.58 | $0.00 |
DisclosureSEC source: 0001019056-19-000616 · maddux_4.xml · derivative · entry 1 Maddux Randy Joe · CIK 0001683826 · SVP Operations, CMO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,359 Underlying: Common Stock · 122,359 shares Expires 2029-10-31 F1 · derivative.exercise_date: The options vest on November 1, 2020, the one-year anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.